The instant invention provides compounds of Formula I which are leukotriene biosynthesis inhibitors.
Compounds of Formula I are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents.
[1,2,3]TRIAZOLYL SUBSTITUTED QUINOLINES AND COUMARINS AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS
申请人:Merck Canada Inc.
公开号:EP2118093B1
公开(公告)日:2012-03-21
US7960409B2
申请人:——
公开号:US7960409B2
公开(公告)日:2011-06-14
Pharmaceutical phenylquinoline and chromen-2-one triazole compounds
申请人:Merck Sharp & Dohme Corp.
公开号:US07960409B2
公开(公告)日:2011-06-14
The instant invention provides compounds of Formula I which are leukotriene biosynthesis inhibitors.
Compounds of Formula I are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents.